Search

Author/Creator Venter, Willem D F

1. Dolutegravir with emtricitabine and tenofovir alafenamide or tenofovir disoproxil fumarate versus efavirenz, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection (ADVANCE): week 96 results from a randomised, phase 3, non-inferiority trial. Issue 10 (October 2020)

Authors:
Venter, Willem D F; Sokhela, Simiso; Simmons, Bryony; Moorhouse, Michelle; Fairlie, Lee; Mashabane, Nkuli; Serenata, Celicia; Akpomiemie, Godspower; Masenya, Masebole; Qavi, Ambar; Chandiwana, Nomathemba; McCann, Kaitlyn; Norris, Shane; Chersich, Matthew; Maartens, Gary; Lalla-Edward, Samanta; Vo...
Journal:
Lancet
Issue:
Volume 7:Issue 10(2020)
Page Start:
e666
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Effect of HIV-1 low-level viraemia during antiretroviral therapy on treatment outcomes in WHO-guided South African treatment programmes: a multicentre cohort study. Issue 2 (February 2018)

Authors:
Hermans, Lucas E; Moorhouse, Michelle; Carmona, Sergio; Grobbee, Diederick E; Hofstra, L Marije; Richman, Douglas D; Tempelman, Hugo A; Venter, Willem D F; Wensing, Annemarie M J
Journal:
Lancet infectious diseases
Issue:
Volume 18:Issue 2(2018)
Page Start:
188
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Low-dose ritonavir-boosted darunavir once daily versus ritonavir-boosted lopinavir for participants with less than 50 HIV RNA copies per mL (WRHI 052): a randomised, open-label, phase 3, non-inferiority trial. Issue 7 (July 2019)

Authors:
Venter, Willem D F; Moorhouse, Michelle; Sokhela, Simiso; Serenata, Celicia; Akpomiemie, Godspower; Qavi, Ambar; Mashabane, Nonkululeko; Arulappan, Natasha; Sim, Joel W; Sinxadi, Phumla Z; Wiesner, Lubbe; Maharaj, Ellisha; Wallis, Carole; Boyles, Tom; Ripin, David; Stacey, Sarah; Chitauri, Gila; ...
Journal:
Lancet
Issue:
Volume 6:Issue 7(2019)
Page Start:
e428
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Point-of-Care Tenofovir Urine Testing for the Prediction of Treatment Failure and Drug Resistance During Initial Treatment for Human Immunodeficiency Virus Type 1 (HIV-1) Infection. (22nd September 2022)

Authors:
Hermans, Lucas E; Umunnakwe, Chijioke N; Lalla-Edward, Samanta T; Hebel, Shane K; Tempelman, Hugo A; Nijhuis, Monique; Venter, Willem D F; Wensing, Annemarie M J
Journal:
Clinical infectious diseases
Issue:
Volume 76:Number 3(2023)
Page Start:
e553
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗